XML 24 R28.htm IDEA: XBRL DOCUMENT v2.4.0.8
Notes and Lines of Credit Payable - Additional Information (Detail) (USD $)
 0 Months Ended 1 Months Ended 0 Months Ended 2 Months Ended 0 Months Ended 2 Months Ended 2 Months Ended 0 Months Ended 2 Months Ended 0 Months Ended 2 Months Ended
Dec. 20, 2013
May 21, 2013
Mar. 28, 2014
Apr. 15, 2013
Mar. 31, 2014
Mar. 31, 2013
Mar. 31, 2014
2014 NNA Financing
Mar. 28, 2014
2014 NNA Financing
Jan. 06, 2014
Medical Clinic Acquisition Promissory Notes
Dec. 20, 2013
Medical Clinic Acquisition Promissory Notes
Dec. 07, 2013
Medical Clinic Acquisition Promissory Notes
Sep. 01, 2013
Medical Clinic Acquisition Promissory Notes
Oct. 15, 2012
Medical Clinic Acquisition Promissory Notes
Mar. 31, 2014
Revolving Credit Facility
Dec. 20, 2013
Revolving Credit Facility
Maximum
Dec. 20, 2013
Revolving Credit Facility
Minimum
Mar. 31, 2014
Secured Revolving Credit Facility
Oct. 15, 2013
Secured Revolving Credit Facility
Mar. 31, 2014
Convertible Notes Payable [Member]
Oct. 15, 2012
Senior secured note
SpaGus
Sep. 15, 2012
Senior secured note
SpaGus
Mar. 31, 2014
Senior secured note
SpaGus
Apr. 15, 2013
Senior secured note
Amended
SpaGus
Mar. 31, 2014
Senior secured note
Amended
SpaGus
Mar. 31, 2014
Senior secured note
Amended
Date One
SpaGus
Mar. 31, 2014
Senior secured note
Amended
Date Two
SpaGus
Mar. 31, 2014
Senior secured note
Amended
Date Three
SpaGus
Mar. 31, 2014
Senior secured note
Amended
Date four
SpaGus
Mar. 31, 2014
Term Loan [Member]
Mar. 31, 2014
Revolving Loan [Member]
Senior Secured Note [Line Items]                                                            
Debt, interest rate                                 1.00%         8.929%   8.00%            
Debt, maturity date                                           Oct. 15, 2012   Oct. 15, 2013            
Payment Of Interest On Early Pre Payment Of Debt                                           $ 15,000                
Debt, accrued interest payable date                                                 Dec. 28, 2012 Mar. 31, 2013 Jun. 30, 2013 Oct. 15, 2013    
Payments of Financing Costs, Total                                           5,000                
Payment of financing costs, restricted shares                                             100,000 100,000            
Payment of financing costs, fair value of restricted shares       45,000                                       50,000            
Revolving line of credit carrying amount                           100,000       2,000,000                        
Line of credit facility amount outstanding                           94,765                                
Line of credit facility, interest rate description                           prime rate (as defined) plus 4.50%     (i) three month LIBOR and (ii) six percent (6.24% at January 31, 2014).                         The Revolving Loan bears interest at the rate of three month LIBOR plus six percent per annum.
Line of credit facility, frequency of payment and payment terms                           interest only is payable monthly, and matures June 5, 2014.     Interest is payable on the last business day of each successive month, in arrears, commenced October 31, 2013,                          
Senior notes                                               500,000            
Debt Instrument, Payment Terms         If the Average Daily Value of Trades (“ADVT”) during the prior 90 days as reported by Bloomberg is greater than $100,000, the Note is callable at a price of 105% of the Note’s par value, and if the ADVT is less than $100,000, the Note is callable at a price of 110% of the Note’s par value.       five   eight                                      
Issuance Of Credit Agreement Related To Direct Cost                                 119,500                          
Business Acquisition Fair Value Of Note Interest Rate                 5.30%   5.46% 5.45%                                    
Line of credit facility, maximum borrowing capacity                             4,000,000 2,000,000                            
Proceeds from repayment 500,000                                                          
Issuance Of Common Stock Shares In Payment Of Financing Cost                                           216,000                
Issuance Of Common Stock Value In Payment Of Financing Cost         0 45,000                               25,661                
Proceeds from Issuance of Debt         0 100,000                                   230,000            
Secured debt               7,000,000                                            
Secured line of credit               1,000,000                                            
Convertible debt               2,000,000                                            
Class of warrant or right, number of securities called by warrants or rights               2,000,000                     1,000,000                   3,000,000  
Repayment of first year term loan                                                         87,500  
Repayment of second year term loan                                                         122,500  
Repayment of third year term loan                                                         122,500  
Repayment of fourth year term loan                                                         175,000  
Repayment of fifth year term loan                                                         210,000  
Term Loan accrued interest                                                         8.00%  
Debt Instrument, Unamortized Discount                                                         1,305,435  
Debt Instrument, Fee Amount                                                         80,000  
Amortization Of Debt Discount Premium         19,406 15,170 20,930                                              
Debt Instrument, Face Amount                                     2,000,000                      
Debt Instrument, Convertible, Conversion Price                                     $ 1.00                      
Class of Warrant or Right, Exercise Price of Warrants or Rights         $ 0.01                           $ 1.00                      
Related Party Costs         235,119                                                  
Interest Expense, Related Party         61,513                                                  
Deferred Finance Costs Net         150,101                                                  
Debt Instrument, Periodic Payment                 15,000 10,000     15,000             135,000 135,000                  
Proceeds From Issuance Of Debt Instruments On Fair Value             9,000,000                                              
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate     2.31%   2.31%   2.31%                                              
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate     71.40%   71.40%   71.40%                                              
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price     $ 0.45   $ 0.45   $ 0.45                                              
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate   0.00% 0.00%   0.00%   50.00%                                              
Stock Issued During Period Value For Financing         868,236   899,739                                              
Discount On Shares Issuance         1,100,261 0 1,100,261                                              
Discount On Term Loan         1,254,363 0 1,254,363                                              
Fair Value Of Warrant Liabilities         2,354,624 0 2,354,624                                              
Expected term     7 years   7 years   7 years                                              
Amortization Of Debt Discount             51,072                                              
Amortization Of Debt Discount Premium Related To Equity             7,998                                              
Expeses Related To Contra Additional Paid In Capital             23,505                                              
Term Loan Value Under Agreement             $ 5,745,637